Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 8/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | NOX1 | Q9Y5S8 | 5/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydromethylthionine SCHEMBL12592446 | 1.00 | SNCA (0.50) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL29356148 | 1.00 | SNCA (0.50) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL31159644 | 0.98 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL1577040 | 0.98 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL31159649 | 0.98 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL23683393 | 0.98 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL12470963 | 0.98 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL25194477 | 0.98 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL25199191 | 0.98 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL31159642 | 0.98 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410394-B2 | Composition comprising nicotinamide mononucleotide and leucomethylene blue | ATHERGEN, INC. (US) | 2025-09-09 | — | — | US | claimed |
| US-20250276046-A1 | SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONS | KaloCyte (US) | 2025-09-04 | — | — | US | claimed |
| US-20250268935-A1 | Tumor Treatment | SIESS HAROLD E (US) | 2025-08-28 | — | — | US | claimed |
| EP-4313156-B1 | DISULFIDE-BASED PRODRUG COMPOUNDS | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2025-08-06 | — | — | EP | claimed |
| US-20250235468-A1 | FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION | EASTERN VIRGINIA MEDICAL SCHOOL | 2025-07-24 | — | — | US | claimed |
| WO-2025129232-A1 | METHODS AND DEVICES FOR MEASURING ANTIOXIDANT ACTIVITY IN A FLUID SAMPLE | Memphasys Limited (AU) | 2025-06-26 | — | — | WO | claimed |
| US-20250161323-A1 | FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION | EASTERN VIRGINIA MEDICAL SCHOOL | 2025-05-22 | — | — | US | claimed |
| WO-2025101956-A2 | CONTROL OF ENZYMATIC NUCLEIC ACID SYNTHESIS VIA ELECTROCHEMICAL MEANS | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2025-05-15 | — | — | WO | claimed |
| US-12290523-B2 | Formulation of long-acting levonorgestrel butanoate injectable depot suspension | EASTERN VIRGINIA MEDICAL SCHOOL (US) | 2025-05-06 | — | — | US | claimed |
| US-12257289-B2 | Self-assembling oxygen carrier compositions | KaloCyte, Inc. (US) | 2025-03-25 | — | — | US | claimed |
| WO-1995013079-A1 | METHYLENE BLUE FOR THE TREATMENT OR PROPHYLAXIS OF ANCEPHALOPATHY CAUSED BY IFOSFAMIDE | NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) | 1995-05-18 | — | — | WO | claimed |
| US-5384248-A | Process for measuring an analyte with an oxidase and an oxidizable color reagent and surfactants | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-24 | — | — | US | claimed |
| EP-0402094-A2 | Process for measuring body fluid components | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1990-12-12 | — | — | EP | claimed |
| EP-0097220-B1 | THE STABILIZATION OF LEUCOMETHYLENE BLUE DYES ON A PRINTING SUBSTRATE | International Business Machines Corporation (US) | 1988-06-08 | — | — | EP | claimed |
| EP-0113151-B1 | PRINTING MEDIUM AND USE THEREOF | International Business Machines Corporation (US) | 1988-03-09 | — | — | EP | claimed |
| US-4505399-A | Tamper-indicating device and method | WEINER ROBERT C | 1985-03-19 | — | — | US | claimed |
| EP-0113151-A2 | Printing medium and use thereof | International Business Machines Corporation (US) | 1984-07-11 | — | — | EP | claimed |
| US-4443302-A | Printing medium and use thereof | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1984-04-17 | — | — | US | claimed |
| EP-0097220-A2 | The stabilization of leucomethylene blue dyes on a printing substrate | International Business Machines Corporation (US) | 1984-01-04 | — | — | EP | claimed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12257289-B2 | Self-assembling oxygen carrier compositions | HBG2, HBG1, HBB | SNCA 3800/4885MAPT 4023/4885NOX1 2129/4885 |
| US-20250276046-A1 | SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONS | HBG2, HBG1, HBB | SNCA 3800/4885MAPT 4023/4885NOX1 2129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.